Francis deSouza, Illumina CEO (Photo by Kevin Dietsch/Getty Images)
Illumina prevails over FTC's challenge of $8B Grail buyout
An administrative judge ruled Illumina’s $8 billion acquisition of cancer-testing company Grail didn’t violate antitrust law, Illumina said on Thursday.
A Federal Trade Commission lawsuit …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.